Study: ISET Detects CTCs for Early Diagnosis of Lung Cancer
In a recent study, the ISET test by Rarecells detected lung cancer in patients with no symptoms, allowing for surgical removal prior to metastasis.
Read More
Search Results for: lung cancer
NCCN Guidelines Recommend VeriStrat Testing for NSCLC
Biodesix recently announced the inclusion of its VeriStrat profiling test in updated evidence-based, consensus-driven NCCN Guidelines for managing non-small-cell lung cancer.
Read MoreNGS Oncology Panels Tackle Non-Small Cell Lung Cancer and Colorectal Cancer
Vela Diagnostics, Singapore, has announced the availability of the Sentosa SQ Non-Small Cell Lung Cancer panel and the Sentosa Colorectal Cancer panel for next-generation sequencing-based detection of sequence variants, for research use only by early-access customers.
Read More
Highmark Insurance Company Announces Coverage for VeriStrat Assay
One of the largest insurance companies in the United States, Highmark has announced it will begin providing coverage of the VeriStrat assay to guide second-line treatment decisions for patients with non-small cell lung cancer. Coverage takes effect on October 27, 2014.
Read More
Oncology Diagnostics
In development since the mid-1970s, next-generation sequencing has the ability to transform the focus of cancer diagnosis and treatment to a molecular basis.
Read More